Related Experiment Video
Updated: Jul 2, 2026
09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Neuromyelitis optica: diagnosis, pathogenesis, and treatment
1Multiple Sclerosis Center, University of California San Francisco, 350 Parnassus Avenue, Suite 908, San Francisco, CA 94117, USA. bruce.cree@ucsf.edu
Current Neurology and Neuroscience Reports
|August 21, 2008
Summary
Neuromyelitis optica (NMO) diagnosis is improved by identifying the NMO-IgG biomarker, an autoantibody targeting aquaporin 4 (AQP4). This discovery aids in differentiating NMO from multiple sclerosis and predicting disease recurrence.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
- Neurology
Background:
- Neuromyelitis optica (NMO) diagnosis historically relied on clinical symptoms, often confused with multiple sclerosis.
- The co-occurrence of myelitis and optic neuritis is characteristic of NMO.
- Recent advances have enabled biomarker identification for more accurate NMO diagnosis.
Purpose of the Study:
- To review the discovery and implications of the NMO-IgG biomarker.
- To discuss aquaporin 4 (AQP4) as the target of the NMO-IgG autoantibody.
- To explore the clinical applications, pathology, and treatment of NMO.
Main Methods:
- Review of scientific literature on NMO, NMO-IgG, and aquaporin 4.
- Analysis of diagnostic criteria evolution for NMO.
- Discussion of immunopathological findings related to anti-AQP4 antibodies.
Main Results:
- Identification of NMO-IgG as a highly specific biomarker for NMO.
- Confirmation of aquaporin 4 (AQP4) as the primary target antigen.
- Demonstration of the biomarker's utility in distinguishing NMO from multiple sclerosis.
Conclusions:
- The NMO-IgG biomarker targeting AQP4 has revolutionized NMO diagnosis and understanding.
- NMO is increasingly recognized as an autoimmune disease mediated by humoral factors.
- Advances in understanding anti-AQP4 antibodies are driving new treatment strategies for NMO.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...